Results 101 to 110 of about 15,585 (162)

Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes. [PDF]

Acta Neurochir (Wien)
Li C, Yuan H, Duan C, Feng X, Liu W, Huang J, Huang C, Huang M, Wen Z, Ge R, Lin J, Jin F, Li R, Guo S, Chen C, Liang S, Li X.   +16 more
europepmc   +1 more source

Early aspirin withdrawal versus dual antiplatelet therapy in high-risk patients after percutaneous coronary intervention: Meta-analysis of randomized trials. [PDF]

PLoS Med
Navarese EP, Gurbel P, Tantry U, Talanas G, Grzelakowska K, Umińska J, Jeong YH, Bliden K, Khan SU, Kubica J, Henry TD, Farkouh ME, Kereiakes DJ.   +12 more
europepmc   +1 more source

Current Strategies for Optimizing Antithrombotic Therapy in Patients with Chronic Coronary Syndrome: A Dynamic Approach. [PDF]

TH Open
Selvarajah A, Fabris E, van Leeuwen MAH, Van't Hof A, Hermanides R.   +4 more
europepmc   +1 more source

Evaluation of safety and affection of variable duration of dual antiplatelet therapy using aspirin plus ticagrelor after successful percutaneous coronary intervention for diabetic patients with acute coronary syndrome. [PDF]

BMC Cardiovasc Disord
Ibrahim NEMS, Zaki MTM, Abdel Magid KAF, Fouad KA, Iskandar MMA.   +4 more
europepmc   +1 more source

Safety and efficacy of flow diversion for blood blister aneurysms: A comprehensive systematic review and meta-analysis. [PDF]

Neurosurg Rev
Maroufi SF, Fallahi MS, Thomas AJ, Tonetti DA.   +3 more
europepmc   +1 more source

Risk of clopidogrel resistance in endovascular aneurysm stenting. [PDF]

Surg Neurol Int
Stanton M, Ng W, Jonathan A.
europepmc   +1 more source

Thrombocytosis-associated ticagrelor non-responder status after ECMO-supported primary PCI in STEMI. [PDF]

J Cardiol Cases
Strohhofer C, Alber H, Dörler J.
europepmc   +1 more source

The performance of ASpirin-FREE therapy after successful percutaneous coronary intervention for acute coronary syndrome: the ASFREE prospective pilot study. [PDF]

J Yeungnam Med Sci
Joo D, Jo S, Byoun JT, Cho JY, Yun KH.
europepmc   +1 more source

Safety profile of ticagrelor: an analysis based on literature and database review. [PDF]

BMC Cardiovasc Disord
Liu R, Xiao L, Yan Q, Liu X.
europepmc   +1 more source

Ticagrelor Resistance Causing Acute In-Stent Thrombosis: Successful Management With Prasugrel and Balloon Angioplasty. [PDF]

J Med Cases
Jia K, Rimsky E, Sattarzadeh A, Pradeep AG, Amor MMI.   +4 more
europepmc   +1 more source